Ibritumomab, sometimes referred to as Zevalin, represents a novel form of specific radiotherapy applied to manage certain kinds of non-Hodgkin's lymphoma , particularly recurring follicular lymphoma . This https://www.targetmol.com/compound/ibritumomab